Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases

INTRODUCTION: In the western hemisphere, age-related macular degeneration (AMD) is the leading cause of visual loss in the elderly. Currently approved therapies for AMD include argon laser, photodynamic therapy, and antivascular endothelial growth factor (VEGF) therapy. The index review discusses af...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sophie, Raafay, Akhtar, Abeer, Sepah, Yasir J., Ibrahim, Mohamed, Bittencourt, Millena, Do, Diana V., Nguyen, Quan Dong
Format: Artigo
Langue:Inglês
Publié: Springer Healthcare Communications 2012
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3873045/
https://ncbi.nlm.nih.gov/pubmed/24392297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13554-012-0003-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires